Literature DB >> 16772016

High seroprevalence of antibodies against dengue virus in a prospective study of schoolchildren in Managua, Nicaragua.

Angel Balmaseda1, Samantha N Hammond, Yolanda Tellez, Laurel Imhoff, Yoryelin Rodriguez, Saira I Saborío, Juan C Mercado, Leonel Perez, Elsa Videa, Elvis Almanza, Guillermina Kuan, Miguel Reyes, Leyla Saenz, Juan J Amador, Eva Harris.   

Abstract

To investigate the incidence of dengue virus (DENV) infection in Nicaragua, a 2-year prospective study was conducted in schoolchildren 4-16 years old in the capital city of Managua. Blood samples were collected before the rainy season in 2001, 2002 and 2003, and were assayed for DENV-specific antibodies. Participants were monitored for dengue-like illness, and acute and convalescent blood samples were collected from suspected dengue cases. In 2001 and 2002, 602 and 397 students were recruited, respectively, and paired annual serum samples were available from 467 and 719 participants in 2001-2002 and 2002-2003, respectively. The overall seroprevalence of anti-DENV antibodies was 91%, increasing from 75% at age 4 to 100% at age 16. The incidence of DENV infection was 12% in Year 1 and 6% in Year 2 (P < 0.001). During Year 1, four laboratory-confirmed dengue cases were detected, with one DENV2 isolate; during Year 2, there were six confirmed dengue cases, with one DENV1 isolate. These and additional circulating serotypes were confirmed by plaque reduction neutralisation test. This study demonstrates surprisingly high transmission of DENV in urban Nicaragua.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16772016     DOI: 10.1111/j.1365-3156.2006.01641.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  86 in total

1.  Genome-wide patterns of intrahuman dengue virus diversity reveal associations with viral phylogenetic clade and interhost diversity.

Authors:  Poornima Parameswaran; Patrick Charlebois; Yolanda Tellez; Andrea Nunez; Elizabeth M Ryan; Christine M Malboeuf; Joshua Z Levin; Niall J Lennon; Angel Balmaseda; Eva Harris; Matthew R Henn
Journal:  J Virol       Date:  2012-05-30       Impact factor: 5.103

2.  Antibody-based assay discriminates Zika virus infection from other flaviviruses.

Authors:  Angel Balmaseda; Karin Stettler; Raquel Medialdea-Carrera; Damaris Collado; Xia Jin; José Victor Zambrana; Stefano Jaconi; Elisabetta Cameroni; Saira Saborio; Francesca Rovida; Elena Percivalle; Samreen Ijaz; Steve Dicks; Ines Ushiro-Lumb; Luisa Barzon; Patricia Siqueira; David W G Brown; Fausto Baldanti; Richard Tedder; Maria Zambon; A M Bispo de Filippis; Eva Harris; Davide Corti
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-17       Impact factor: 11.205

3.  Total economic cost and burden of dengue in Nicaragua: 1996-2010.

Authors:  Zachary S Wettstein; Michael Fleming; Aileen Y Chang; David J Copenhaver; Angela R Wateska; Sarah M Bartsch; Bruce Y Lee; Rajan P Kulkarni
Journal:  Am J Trop Med Hyg       Date:  2012-08-13       Impact factor: 2.345

4.  Incidence of dengue virus infection in school-aged children in Puerto Rico: a prospective seroepidemiologic study.

Authors:  D Fermín Argüello; Kay M Tomashek; Luz Quiñones; Manuela Beltran; Luz Acosta; Luis M Santiago; Brad J Biggerstaff; Enid J Garcia-Rivera; Wellington Sun; Laurence Pollissard-Gadroy; Christine Luxemburger; Elizabeth Hunsperger
Journal:  Am J Trop Med Hyg       Date:  2015-02-02       Impact factor: 2.345

5.  Comparison of Four Serological Methods and Two Reverse Transcription-PCR Assays for Diagnosis and Surveillance of Zika Virus Infection.

Authors:  Angel Balmaseda; José Victor Zambrana; Damaris Collado; Nadezna García; Saira Saborío; Douglas Elizondo; Juan Carlos Mercado; Karla Gonzalez; Cristhiam Cerpas; Andrea Nuñez; Davide Corti; Jesse J Waggoner; Guillermina Kuan; Raquel Burger-Calderon; Eva Harris
Journal:  J Clin Microbiol       Date:  2018-02-22       Impact factor: 5.948

6.  Characterization of Dengue Virus Infections Among Febrile Children Clinically Diagnosed With a Non-Dengue Illness, Managua, Nicaragua.

Authors:  Jesse J Waggoner; Lionel Gresh; Alisha Mohamed-Hadley; Angel Balmaseda; K James Soda; Janaki Abeynayake; Malaya K Sahoo; Yuanyuan Liu; Guillermina Kuan; Eva Harris; Benjamin A Pinsky
Journal:  J Infect Dis       Date:  2017-06-15       Impact factor: 5.226

7.  Phenotyping of peripheral blood mononuclear cells during acute dengue illness demonstrates infection and increased activation of monocytes in severe cases compared to classic dengue fever.

Authors:  Anna P Durbin; Maria José Vargas; Kimberli Wanionek; Samantha N Hammond; Aubree Gordon; Crisanta Rocha; Angel Balmaseda; Eva Harris
Journal:  Virology       Date:  2008-05-02       Impact factor: 3.616

8.  Epidemiology of dengue virus in Iquitos, Peru 1999 to 2005: interepidemic and epidemic patterns of transmission.

Authors:  Amy C Morrison; Sharon L Minnick; Claudio Rocha; Brett M Forshey; Steven T Stoddard; Arthur Getis; Dana A Focks; Kevin L Russell; James G Olson; Patrick J Blair; Douglas M Watts; Moises Sihuincha; Thomas W Scott; Tadeusz J Kochel
Journal:  PLoS Negl Trop Dis       Date:  2010-05-04

9.  Age and clinical dengue illness.

Authors:  Joseph R Egger; Paul G Coleman
Journal:  Emerg Infect Dis       Date:  2007-06       Impact factor: 6.883

10.  Dengue fever seroprevalence and risk factors, Texas-Mexico border, 2004.

Authors:  Joan Marie Brunkard; Jose Luis Robles López; Josue Ramirez; Enrique Cifuentes; Stephen J Rothenberg; Elizabeth A Hunsperger; Chester G Moore; Regina M Brussolo; Norma A Villarreal; Brent M Haddad
Journal:  Emerg Infect Dis       Date:  2007-10       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.